Overview

A Study of LY900010 in Erectile Dysfunction

Status:
Completed

Trial end date:
2011-11-01

Target enrollment:

Participant gender:

Summary

The primary purpose of the study is to compare the efficacy of LY2452473 + tadalafil to tadalafil alone in improving the erectile function (EF) of men with erectile dysfunction (ED) who incompletely respond to tadalafil alone.

Phase:

Phase 2

Details

Lead Sponsor:

Eli Lilly and Company

Treatments:

Tadalafil